🇺🇸 FDA
Patent

US 11992495

Enhancing GABA's ability to modulate immune responses

granted A61KA61K31/5513A61K31/5517

Quick answer

US patent 11992495 (Enhancing GABA's ability to modulate immune responses) held by The Regents of the University of California expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/5513, A61K31/5517, A61K31/57, A61K45/06